Search research articles
Contact Us
Filters
Showing results (11-20 of 60) with videos related to
Page
of 6
Sort By:
Human Vaccines
|
September 24, 2010
Development of Sanofi Pasteur tetravalent dengue vaccine
Bruno Guy, Melanie Saville, Jean Lang
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy
|
March 30, 2004
Immunological foundations to the quest for new vaccine adjuvants
Nicolas Burdin, Bruno Guy, Philippe Moingeon
Virologie (Montrouge, France)
|
September 24, 2022
[Tetravalent dengue vaccine development]
Bruno Guy, Mélanie Saville, Jean Lang
Annual Review of Medicine
|
October 31, 2015
Vaccination Against Dengue: Challenges and Current Developments
Bruno Guy, Jean Lang, Melanie Saville, et al.
Vaccine
|
September 8, 2016
Potential impact of dengue vaccination: Insights from two large-scale phase III trials with a tetravalent dengue vaccine
Laurent Coudeville, Nicolas Baurin, Maïna L'Azou, et al.
Expert Opinion on Drug Metabolism & Toxicology
|
June 2, 2026
Complex in vitro model developers' perspective on advanced hepatic in vitro culture methods for predictive drug safety
Maria Vittoria Colombo, Anna Borgström, Bruno Guy Henri Filippi
Journal of Medical Microbiology
|
April 13, 2005
Identification of two new Helicobacter pylori surface proteins involved in attachment to epithelial cell lines
Sebastian Rubinsztein-Dunlop, Bruno Guy, Ling Lissolo, et al.
FEMS Immunology and Medical Microbiology
|
January 20, 2006
Comparison by flow cytometry of immune changes induced in human monocyte-derived dendritic cells upon infection with dengue 2 live-attenuated vaccine or 16681 parental strain
Violette Sanchez, Catherine Hessler, Aymeric DeMonfort, et al.
Clinical and Diagnostic Laboratory Immunology
|
March 5, 2002
Depletion of human NK and CD8 cells prior to in vitro H1N1 flu vaccine stimulation increases the number of gamma interferon-secreting cells compared to the initial undepleted population in an ELISPOT assay
Christophe Dercamp, Violette Sanchez, Julie Barrier, et al.
Vaccine
|
October 18, 2015
Development of the Sanofi Pasteur tetravalent dengue vaccine: One more step forward
Bruno Guy, Olivier Briand, Jean Lang, et al.
Page
of 6
Search research articles
Search
Showing results (11-20 of 60) with videos related to
Sort By:
Page
of 6
Human Vaccines
|
September 24, 2010
Development of Sanofi Pasteur tetravalent dengue vaccine
Bruno Guy, Melanie Saville, Jean Lang
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy
|
March 30, 2004
Immunological foundations to the quest for new vaccine adjuvants
Nicolas Burdin, Bruno Guy, Philippe Moingeon
Virologie (Montrouge, France)
|
September 24, 2022
[Tetravalent dengue vaccine development]
Bruno Guy, Mélanie Saville, Jean Lang
Annual Review of Medicine
|
October 31, 2015
Vaccination Against Dengue: Challenges and Current Developments
Bruno Guy, Jean Lang, Melanie Saville, et al.
Vaccine
|
September 8, 2016
Potential impact of dengue vaccination: Insights from two large-scale phase III trials with a tetravalent dengue vaccine
Laurent Coudeville, Nicolas Baurin, Maïna L'Azou, et al.
Expert Opinion on Drug Metabolism & Toxicology
|
June 2, 2026
Complex in vitro model developers' perspective on advanced hepatic in vitro culture methods for predictive drug safety
Maria Vittoria Colombo, Anna Borgström, Bruno Guy Henri Filippi
Journal of Medical Microbiology
|
April 13, 2005
Identification of two new Helicobacter pylori surface proteins involved in attachment to epithelial cell lines
Sebastian Rubinsztein-Dunlop, Bruno Guy, Ling Lissolo, et al.
FEMS Immunology and Medical Microbiology
|
January 20, 2006
Comparison by flow cytometry of immune changes induced in human monocyte-derived dendritic cells upon infection with dengue 2 live-attenuated vaccine or 16681 parental strain
Violette Sanchez, Catherine Hessler, Aymeric DeMonfort, et al.
Clinical and Diagnostic Laboratory Immunology
|
March 5, 2002
Depletion of human NK and CD8 cells prior to in vitro H1N1 flu vaccine stimulation increases the number of gamma interferon-secreting cells compared to the initial undepleted population in an ELISPOT assay
Christophe Dercamp, Violette Sanchez, Julie Barrier, et al.
Vaccine
|
October 18, 2015
Development of the Sanofi Pasteur tetravalent dengue vaccine: One more step forward
Bruno Guy, Olivier Briand, Jean Lang, et al.
Page
of 6